Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Low Dose Ketamine Infusion for Analgesia in the Emergency Department (ED) to Reduce Side Effects: A Double Blind, Double Dummy Randomized Controlled Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05518877

Organisation Name: Summa Health System

Overal Status: Not yet recruiting

Start Date: November 15, 2022

Last Update: September 28, 2022

Lead Sponsor: Summa Health System

Brief Summary: This will be an intent to treat prospective, double blind, double-dummy, randomized trial. Our primary objective is the reduction of side effects of sub dissociative dose ketamine given by slow intravenous (IV) infusion over 30 minutes vs. 15 minutes in the treatment of acute, severe pain in Emergency Department (ED) patients. The secondary objective will be to maintain adequate pain control (as defined by a Visual Analog Scale (VAS) score of ≤ 5cm) at 30 minutes for both groups.

Conditions:
  • Pain, Acute
  • Dissociation


Total execution time in seconds: 0.21008896827698